SCHEMBL31240369

SCHEMBL31240369

CN(C)Cc1c(F)cc(-c2cc3c(-c4ccc5[nH]nc(N)c5c4)ccnc3[nH]2)cc1F

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHUK O15111 3/20 0.47
▸ INSR P06213 3/20 0.47
▸ MAPK8 P45983 3/20 0.47
▸ CAMKK2 Q96RR4 3/20 0.47
▸ DYRK1A Q13627 9/20 0.46
▸ CLK2 P49760 8/20 0.46
▸ CLK3 P49761 7/20 0.46
▸ AURKA O14965 2/20 0.45
▸ AURKB Q96GD4 2/20 0.45
▸ INCENP Q9NQS7 2/20 0.45
▸ TPX2 Q9ULW0 2/20 0.45
▸ TBK1 Q9UHD2 2/20 0.40
▸ WNT1 P04628 1/20 0.40
▸ ALOX5AP P20292 1/20 0.40
▸ FEN1 P39748 1/20 0.40
▸ CCNT1 O60563 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240410 0.91 DYRK1A (0.44) CHUKINSRMAPK8CAMKK2DYRK1A
SCHEMBL31240583 0.88 CLK2 (0.42) CHUKINSRMAPK8CAMKK2DYRK1A
SCHEMBL31240632 0.86 CLK2 (0.41) CHUKINSRMAPK8CAMKK2DYRK1A
SCHEMBL31240766 0.83 AURKA (0.47) CHUKINSRMAPK8CAMKK2DYRK1A
SCHEMBL31240498 0.83 CLK2 (0.52) DYRK1ACLK2CLK3WNT1CCNT1
SCHEMBL31240596 0.83 CLK2 (0.48) CHUKINSRMAPK8CAMKK2DYRK1A
SCHEMBL31240700 0.82 CLK2 (0.58) DYRK1ACLK2CLK3TBK1JAK2
SCHEMBL31240412 0.82 CLK2 (0.51) DYRK1ACLK2CLK3WNT1JAK2
SCHEMBL31240258 0.82 DYRK1A (0.44) DYRK1ACLK2CLK3TBK1WNT1
SCHEMBL31240586 0.80 CLK2 (0.52) DYRK1ACLK2CLK3WNT1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback